CRP and non-small cell lung carcinoma: In NSCLC, research on the association between routine blood markers and progression has focused on inflammatory markers (Tanizaki et al. 2018; Iivanainen et al. 2019; Inomata et al. 2020; Peng et al. 2020; Chen et al. 2023), including the C reactive protein (CRP) and the neutrophil/lymphocyte ratio, lactate dehydrogenase (LDH) (Tanizaki et al. 2018; Inomata et al. 2020; Zhang et al. 2022) and albumin (Li et al. 2022; Menekse et al. 2023).